Latest article
Lilly’s tirzepatide beats Ozempic in head-to-head kind 2 diabetes trial
Eli Lilly announced that its investigated GIP and GLP-1 inhibitor tirzepatide has demonstrated superiority over Novo Nordisk's Ozempic in a Phase III study.The SURPASS-2...
Girls Diet Market 2022 – Newest Gross sales Determine Alerts Extra Alternatives Forward –...
Women Nutrition Market Research 2022-2027:
Get sample report Inquiry Before Buy Order report now
The Global Women Nutrition Market report provides information about the Global industry,...
Mandarin Important Oil Market 2021 Development Drivers, Funding Alternative and Product Developments 2028
New Jersey, United States, - The latest research report added to Intellect Repository of market research is an in-depth analysis of the worldwide Mandarin...